American Medical Association (AMA)@AmerMedicalAssn) announcements editorial update of Current procedural terminology (CPT®)the country’s leading medical terminology code, a set of descriptions of procedures and services in healthcare, which includes newly assigned temporary CPT codes for candidates to strengthen COVID-19 from Pfizer and Sanofi-GlaxoSmithKline.

The Pfizer Booster Applicant is available for use in children aged 5 to 11 years who have completed a primary batch of COVID-19 vaccine, while the Sanofi-GSK Booster Applicant is available for use in individuals 18 years of age and older. who have completed a vaccine against the COVID-19 primary series.

Any temporary CPT code is effective for use provided that its designated booster candidate has been authorized for emergency use by the US Food and Drug Administration (FDA). The AMA is publishing an update to the CPT code now to ensure that electronic systems throughout the U.S. health care system are prepared in advance for potential FDA approval.

As the highly contagious coronavirus sub-variant Omicron BA.2 causes an increase in COVID-19 infections across the country, the American Medical Association continues to urge every eligible individual to ensure that they are up to date with their COVID vaccination. 19, including booster doses, ”said AMA President Gerald E. Harmon, MD. initial booster dose. We urge patients to check CDC Guidelines on COVID-19 boosters and review available options with your doctor. “

CPT codes clinically differentiate between each coronavirus vaccine and dosing schedule to allow data-driven tracking, reporting, and analysis that support planning and allocation during the pandemic public health response. To date, 35 CPT codes have been developed for reporting COVID-19 vaccines.

To help ensure accurate coding and reporting of vaccines and immunization services against COVID-19, the AMA offers vaccine code resource to help identify the appropriate combination of CPT code for the type and dose of COVID-19 vaccine provided to each patient.

For quick reference, the new product code and administrative codes assigned to each COVOVID-19 booster candidate are:

Product and administrative codes for Sanofi-GSK Booster Candidate

  • 91310 – Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [COVID-19]) vaccine, monovalent, preservative-free, 5 mcg / 0.5 mL dose, adjuvant AS03 emulsion, for intramuscular use
  • 0104A – Immunization use by intramuscular injection of severe acute coronavirus 2 respiratory syndrome (SARS-CoV-2) (coronavirus disease) [COVID-19]) vaccine, monovalent, preservative-free, 5 mcg / 0.5 mL dose, adjuvant AS03 emulsion, booster dose

Pfizer Booster Candidate Administrative Code

  • 0074A – Immunization use by intramuscular injection of severe acute coronavirus 2 respiratory syndrome (SARS-CoV-2) (coronavirus disease) [COVID-19]) vaccine, mRNA-LNP, spike protein, no preservatives, dose 10 mcg / 0.2 mL, dissolved diluent, tris-sucrose formulation; booster dose

Short, medium and long descriptors for all new vaccine-specific CPT codes can be made available at AMA websitetogether with other recent modifications to the CPT code set that have helped streamline the public health response to SARS-CoV-2 and COVID-19.

Changes to the CPT’s code set are addressed through an open editorial process managed by the CPT’s editorial panel, which brings together broad input from the healthcare community and beyond to ensure that the CPT’s content reflects digital health coding requirements, precision medicine, advanced intelligence and other aspects of the modern health care system. This rigorous editorial process keeps the CPT code up-to-date with modern medical science and technology so that it can fulfill its vital role as a reliable language of medicine today and a code for its future.

Questions about CPT coding and content should be addressed to CPT network, the authoritative source for CPT coding responses. Also consult AMA’s online library COVID-19 CPT coding and guidelines.

About the American Medical Association
IN American Medical Association is a powerful ally of physicians in patient care. As the only medical association that brings together more than 190 state and specialized medical societies and other critical stakeholders, the AMA represents doctors with a unanimous voice to all key players in healthcare. The AMA uses its power to remove barriers to patient care by focusing on preventing chronic diseases and tackling public health crises, and by directing the future of medicine to address the greatest health challenges.


AMA Announces CPT Update for COVID-19 Booster Candidates

Previous articleMaking hiring IT talent a business priority
Next articleSilk skeletons loaded with stem cells accelerate the healing of damaged tendons